tirzepatide lawsuit CVS Caremark stopped covering a GLP-1 for obesity. Now there's a Lilly seeks to intervene in

Interestingly, 14.3% of patients reported headache, 8.9% dyspepsia, 7.1% vomiting, 7.1% decreased appetite and 5.4% diarrhea

Weeks 2-3 Appetite decreased noticeably in trials

The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial

Most patients feel better by: Eating smaller meals Staying upright after eating Avoiding trigger foods Adjusting timing and pace Working closely with their provider With the right support, GLP-1 therapy can remain both effective and comfortable

10.1016/j.pharmthera.2010.01.006 228 Van HorssenJ.WitteM

Storage and handling are the responsibility of the qualified purchaser or laboratory